{{Rsnum
|rsid=13250873
|Chromosome=8
|position=116793930
|Orientation=plus
|GMAF=0.4238
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.9 | 54.9 | 6.2
| HCB | 5.1 | 37.2 | 57.7
| JPT | 2.7 | 32.7 | 64.6
| YRI | 0.0 | 17.0 | 83.0
| ASW | 3.5 | 33.3 | 63.2
| CHB | 5.1 | 37.2 | 57.7
| CHD | 5.5 | 37.6 | 56.9
| GIH | 38.6 | 47.5 | 13.9
| LWK | 0.0 | 15.5 | 84.5
| MEX | 29.3 | 55.2 | 15.5
| MKK | 0.6 | 22.4 | 76.9
| TSI | 47.5 | 45.5 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22258532
|Title=A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}